Physician

Jeffrey S Rapkin, MD

According to 2025 Medicare claims, Jeffrey Rapkin, MD (NPI: 1144203274) practices ophthalmology in the Muncie, IN market, with the plurality of this provider's patient population coming from Delaware, IN. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF INDIANA & OHIO, PC. (NPI: 1083940936; TIN: 27-1080507) and primary practice location at 47304-2254.

Rapkin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 419 traditional Medicare patients, billed 205,374 HCPCS/CPT codes, and received $763,755 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 938 prescription claims across 272 beneficiaries totaling $46,390 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 16 records totaling $342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$382K$764K2015 Medicare payment: $464,860 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $357,528 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $388,124 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $427,560 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $504,629 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $398,614 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $294,577 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $237,670 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $301,520 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $763,755 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156958,122$464,860
20167256,286$357,528
20177106,384$388,124
20185946,274$427,560
20196014,491$504,629
20205414,141$398,614
20214853,413$294,577
20224342,995$237,670
20234232,940$301,520
2024419205,374$763,755

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$53K2015 Drug cost: $29,683 (USD; Tot_Drug_Cst)2016 Drug cost: $40,593 (USD; Tot_Drug_Cst)2017 Drug cost: $49,400 (USD; Tot_Drug_Cst)2018 Drug cost: $45,075 (USD; Tot_Drug_Cst)2019 Drug cost: $52,753 (USD; Tot_Drug_Cst)2020 Drug cost: $44,272 (USD; Tot_Drug_Cst)2021 Drug cost: $35,328 (USD; Tot_Drug_Cst)2022 Drug cost: $40,618 (USD; Tot_Drug_Cst)2023 Drug cost: $39,609 (USD; Tot_Drug_Cst)2024 Drug cost: $46,390 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015175568$29,683
2016209717$40,593
2017230884$49,400
2018211808$45,075
2019221769$52,753
2020198659$44,272
2021191612$35,328
2022212694$40,618
2023232752$39,609
2024272938$46,390

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye9099$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more121166$80
67028Injection of drug into eye114586$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more249360$56
92134Imaging of retina344583$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol14600$4,339
Ciprofloxacin HclCiprofloxacin Hcl4366,319$3,660
Loteprednol EtabonateLoteprednol Etabonate28742$3,606
Brimonidine TartrateBrimonidine Tartrate25886$3,301
Prednisolone AcetatePrednisolone Acetate431,078$1,243

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$342Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey S. Rapkin, MD?

Tedicare shows public-source Medicare data for Jeffrey S. Rapkin, MD (NPI 1144203274), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey S. Rapkin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey S. Rapkin, MD?

Jeffrey S. Rapkin, MD is linked to RETINA CONSULTANTS OF INDIANA & OHIO, PC. (billing NPI 1083940936) in the available physician profile data.

Does Jeffrey S. Rapkin, MD have Open Payments data?

Jeffrey S. Rapkin, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.